APA (7th ed.) Citation

Bostwick, D. G., Wilk, M. M., Bostwick, B. R., Rydesky, P. M., Littrup, P. J., Cribbs, M., . . . Qian, J. (2023). 706 First-in-human phase 2 clinical trial of multiplex combination intratumoral immunotherapy (MCII) in patients with metastatic solid cancer (Abscopal 5001 trial). BMJ Publishing Group.

Chicago Style (17th ed.) Citation

Bostwick, David G., et al. 706 First-in-human Phase 2 Clinical Trial of Multiplex Combination Intratumoral Immunotherapy (MCII) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial). BMJ Publishing Group, 2023.

MLA (9th ed.) Citation

Bostwick, David G., et al. 706 First-in-human Phase 2 Clinical Trial of Multiplex Combination Intratumoral Immunotherapy (MCII) in Patients with Metastatic Solid Cancer (Abscopal 5001 Trial). BMJ Publishing Group, 2023.